Stay updated on Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page adds a 2015 U.S. NIH grant/contract acknowledgment and updates the revision tag from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T22:22:42.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added page revision v3.6.5 to replace v3.6.4, indicating a new version of the page has been published. This appears to reflect internal fixes or small tweaks rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-08-09T11:04:18.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, indicating an updated version of the record; this reflects administrative maintenance rather than a modification to the study details.
    Difference
    0.0%
    Check dated 2026-07-25T18:20:09.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The revision history shows a update to version v3.6.3, indicating a software/maintenance update to the page’s underlying system, with no changes to the displayed study data.
    Difference
    0.0%
    Check dated 2026-07-04T10:09:23.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page's revision tag updated from v3.6.0 to v3.6.2, signaling a new version of the study documentation rather than a substantive update to trial details.
    Difference
    0.0%
    Check dated 2026-06-27T06:30:47.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates header labels (Intervention/Treatment) while removing the older label (Intervention / Treatment) and the older revision note (Revision: v3.5.5), and introduces a new revision version (Revision: v3.6.0). Additionally, recruitment status is updated with 'No longer looking for participants', indicating that enrollment is closed.
    Difference
    0.4%
    Check dated 2026-06-13T01:39:36.000Z thumbnail image

Stay in the know with updates to Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.